(-)-demecolcine increases expression ISO ARL5B (Homo sapiens) 6480464 Demecolcine results in increased expression of ARL5B mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARL5B mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ARL5B mRNA CTD PMID:22206623 15-acetyldeoxynivalenol increases expression ISO ARL5B (Homo sapiens) 6480464 15-acetyldeoxynivalenol results in increased expression of ARL5B mRNA CTD PMID:23792671 17alpha-ethynylestradiol increases expression ISO Arl5b (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of ARL5B mRNA CTD PMID:29097150 17beta-estradiol affects expression ISO Arl5b (Rattus norvegicus) 6480464 Estradiol affects the expression of ARL5B mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO ARL5B (Homo sapiens) 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARL5B promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Arl5b (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ARL5B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ARL5B mRNA CTD PMID:21570461 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ARL5B mRNA CTD PMID:26251327 acetaldehyde increases expression ISO ARL5B (Homo sapiens) 6480464 Acetaldehyde results in increased expression of ARL5B mRNA CTD PMID:23416264 acrolein multiple interactions ISO ARL5B (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ARL5B mRNA CTD PMID:32699268 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ARL5B mRNA CTD PMID:19770486 aflatoxin M1 decreases expression ISO ARL5B (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of ARL5B mRNA CTD PMID:30928695 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of ARL5B mRNA CTD PMID:17178593 alpha-pinene multiple interactions ISO ARL5B (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ARL5B mRNA CTD PMID:32699268 aristolochic acid A decreases expression ISO ARL5B (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of ARL5B mRNA CTD PMID:33212167 arsenous acid increases expression ISO ARL5B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of ARL5B mRNA CTD PMID:22521957 benzo[a]pyrene increases expression ISO ARL5B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ARL5B mRNA CTD PMID:20106945 benzo[a]pyrene diol epoxide I decreases expression ISO ARL5B (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 bisphenol A affects expression ISO Arl5b (Rattus norvegicus) 6480464 bisphenol A affects the expression of ARL5B mRNA CTD PMID:32145629 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 CGP 52608 multiple interactions ISO ARL5B (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to ARL5B gene] CTD PMID:28238834 cisplatin decreases expression ISO ARL5B (Homo sapiens) 6480464 Cisplatin results in decreased expression of ARL5B mRNA CTD PMID:27392435 cisplatin multiple interactions ISO ARL5B (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ARL5B mRNA CTD PMID:27392435 copper atom multiple interactions ISO ARL5B (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of ARL5B mRNA CTD PMID:20971185 copper(0) multiple interactions ISO ARL5B (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of ARL5B mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO ARL5B (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ARL5B mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO ARL5B (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of ARL5B mRNA CTD PMID:18687144 cyclosporin A increases expression ISO ARL5B (Homo sapiens) 6480464 Cyclosporine results in increased expression of ARL5B mRNA CTD PMID:20106945 more ... D-glucose increases expression EXP 6480464 Glucose results in increased expression of ARL5B mRNA CTD PMID:17178593 diarsenic trioxide increases expression ISO ARL5B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of ARL5B mRNA CTD PMID:22521957 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ARL5B mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO ARL5B (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA CTD PMID:27188386 doxorubicin decreases expression ISO ARL5B (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ARL5B mRNA CTD PMID:29803840 endosulfan increases expression ISO Arl5b (Rattus norvegicus) 6480464 Endosulfan results in increased expression of ARL5B mRNA CTD PMID:29391264 entinostat multiple interactions ISO ARL5B (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA CTD PMID:27188386 entinostat increases expression ISO ARL5B (Homo sapiens) 6480464 entinostat results in increased expression of ARL5B mRNA CTD PMID:26272509 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARL5B mRNA CTD PMID:28329830 gentamycin increases expression ISO Arl5b (Rattus norvegicus) 6480464 Gentamicins results in increased expression of ARL5B mRNA CTD PMID:33387578 glucose increases expression EXP 6480464 Glucose results in increased expression of ARL5B mRNA CTD PMID:17178593 gold atom decreases expression ISO ARL5B (Homo sapiens) 6480464 Gold results in decreased expression of ARL5B mRNA CTD PMID:25523186 gold(0) decreases expression ISO ARL5B (Homo sapiens) 6480464 Gold results in decreased expression of ARL5B mRNA CTD PMID:25523186 graphite affects expression ISO Arl5b (Rattus norvegicus) 6480464 Graphite affects the expression of ARL5B mRNA CTD PMID:29933104 hydrogen cyanide increases expression EXP 6480464 Hydrogen Cyanide results in increased expression of ARL5B mRNA CTD PMID:33914522 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ARL5B mRNA CTD PMID:36331819 leflunomide increases expression ISO ARL5B (Homo sapiens) 6480464 leflunomide results in increased expression of ARL5B mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO ARL5B (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of ARL5B mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO ARL5B (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARL5B mRNA CTD PMID:35811015 mercury dichloride increases expression ISO Arl5b (Rattus norvegicus) 6480464 Mercuric Chloride results in increased expression of ARL5B mRNA CTD PMID:16507785 methamphetamine increases expression ISO Arl5b (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of ARL5B mRNA CTD PMID:19564919 methamphetamine multiple interactions ISO Arl5b (Rattus norvegicus) 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of ARL5B mRNA CTD PMID:19564919 methyl methanesulfonate increases expression ISO ARL5B (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of ARL5B mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO ARL5B (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of ARL5B mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO ARL5B (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of ARL5B mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium increases expression ISO Arl5b (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ARL5B mRNA CTD PMID:28801915 nickel atom increases expression ISO ARL5B (Homo sapiens) 6480464 Nickel results in increased expression of ARL5B mRNA CTD PMID:23195993 more ... ozone multiple interactions ISO ARL5B (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA more ... CTD PMID:32699268 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARL5B mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ARL5B mRNA CTD PMID:34911549 paracetamol multiple interactions EXP 6480464 MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARL5B mRNA] CTD PMID:18700144 paracetamol increases expression ISO Arl5b (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of ARL5B mRNA CTD PMID:33387578 paracetamol increases expression ISO ARL5B (Homo sapiens) 6480464 Acetaminophen results in increased expression of ARL5B mRNA CTD PMID:26690555 perfluorooctane-1-sulfonic acid decreases expression ISO ARL5B (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of ARL5B mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARL5B mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ARL5B mRNA CTD PMID:36331819 phenobarbital affects expression ISO ARL5B (Homo sapiens) 6480464 Phenobarbital affects the expression of ARL5B mRNA CTD PMID:19159669 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of ARL5B mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO ARL5B (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARL5B mRNA CTD PMID:19710929 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARL5B mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of ARL5B mRNA CTD PMID:20813756 potassium cyanide increases expression EXP 6480464 Potassium Cyanide results in increased expression of ARL5B mRNA CTD PMID:33914522 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of ARL5B mRNA CTD PMID:23608068 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO ARL5B (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARL5B mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO ARL5B (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA CTD PMID:27188386 SCH 23390 multiple interactions ISO Arl5b (Rattus norvegicus) 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of ARL5B mRNA CTD PMID:19564919 SCH 23390 increases expression ISO Arl5b (Rattus norvegicus) 6480464 SCH 23390 results in increased expression of ARL5B mRNA CTD PMID:19564919 silicon dioxide increases expression ISO ARL5B (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of ARL5B mRNA CTD PMID:23806026 silver atom decreases expression EXP 6480464 Silver results in decreased expression of ARL5B mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of ARL5B mRNA CTD PMID:27131904 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ARL5B mRNA CTD PMID:31919559 thioacetamide increases expression ISO Arl5b (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of ARL5B mRNA CTD PMID:23411599 and PMID:34492290 torcetrapib increases expression ISO ARL5B (Homo sapiens) 6480464 torcetrapib results in increased expression of ARL5B mRNA CTD PMID:23228038 trichostatin A affects expression ISO ARL5B (Homo sapiens) 6480464 trichostatin A affects the expression of ARL5B mRNA CTD PMID:28542535 triptonide increases expression EXP 6480464 triptonide results in increased expression of ARL5B mRNA CTD PMID:33045310 tungsten increases expression EXP 6480464 Tungsten results in increased expression of ARL5B mRNA CTD PMID:30912803 valproic acid decreases expression ISO ARL5B (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ARL5B mRNA CTD PMID:23179753 and PMID:27188386 vinclozolin decreases expression ISO Arl5b (Rattus norvegicus) 6480464 vinclozolin results in decreased expression of ARL5B mRNA CTD PMID:23869203 vincristine increases expression ISO ARL5B (Homo sapiens) 6480464 Vincristine results in increased expression of ARL5B mRNA CTD PMID:23649840 zinc atom multiple interactions ISO ARL5B (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ARL5B mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO ARL5B (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ARL5B mRNA CTD PMID:18593933 zoledronic acid increases expression ISO ARL5B (Homo sapiens) 6480464 zoledronic acid results in increased expression of ARL5B mRNA CTD PMID:20977926